Browsing category:

Antibiotic


When penicillin was discovered in 1928 by Alexander Fleming no one knew quite how great of an impact this drug would make on the world. The actual use of penicillin to treat infection did not begin until the mid-1940s,  when a powdery form of this medication was developed by Howard Florey and Ernst Chain.  The[…]

Read More

Ciprofloxacin Hydrochloride, known as the brand name antibiotic Proquin XR, is an effectual fluoroquinolone. Marketed by Depomed, the patent for Proquin XR is set to expire on September 19, 2016. It is projected to flourish as a generic antibiotic, due in part to its ease of use as a once daily 500 milligram dose. Another[…]

Read More

Gemifloxacin Mesylate is a reliable and effectual antibiotic. Known as Factive, which is marketed by LG Life Sciences, the patent for gemifloxacin mesylate is due to expire on June 15, 2015. This once daily, 320 milligram tablet is the only FDA approved drug indicated for the treatment of acute bacterial exacerbation of chronic bronchitis caused[…]

Read More

Gatifloxacin is a quinolone antibiotic also known as Tequin. While Tequin, which is marketed by Bristol- Myers Squibb is no longer sold as a tablet in the U.S., it is still sold in other countries in tablet form, like China. In the United States gatifloxacin is sold as an opthalmic solution, also known as Zymar,[…]

Read More

As a chronic disease which occurs when the body does not properly produce, or use the hormone insulin, type 2 diabetes has become a worldwide problem. Roughly 25.8 million Americans and an estimated 366 million people worldwide have diabetes, according to the CDC and 2011 data from the IDF. Type 2 diabetes accounts for 90-95[…]

Read More

Ceftibuten Hydrate, CAS number 118081-34-8, is a cephalosporin antibiotic. Used as a treatment for bacterial infections such as bronchitis and ear infections, ceftibuten can also be found by it’s brand name, Cedax. Cedax is manufactured by Pernix Therapeutics, who purchased the drug in March 2010 from Shionogi Pharma Inc. Ceftibuten is an effective third generation[…]

Read More

Meropenem, CAS number 96036-03-2, is a broad spectrum antibiotic, effective for both gram negative and gram positive bacteria, including pseudonomas. An injectable antibiotic, meropenem was approved for use by the FDA in July of 1996. Developed by Sumitomo Pharmaceuticals, meropenem is marketed by AstraZeneca in the United States with the brand names Merrem and Meronem.[…]

Read More

Gonorrhea is a sexually transmitted disease (STD) caused by the bacterium Neisseria Gonorrhoeae. Gonorrhea is a very common infectious disease among the sexually active young adults and teens. The Center for Disease Control and Prevention (CDC) estimates that more than 700,000 persons in the U.S. acquire the infection yearly. Unlike HIV, exchange of body fluids[…]

Read More

Ramoplanin is an antibiotic glycolipodepsipeptide drug that can be used as a treatment for patients suffering with Clostridium difficile infection (CDAD infection) of the gastrointestinal tract. This drug was approved by the US Food and Drug Administration (FDA); however, this drug is considered unstable in the blood, and it degrades to inactive parts. Therefore, Ramoplanin[…]

Read More

This website uses cookies. By using our site, you agree to our terms of service